Infinity Pharmaceuticals reported $9.98M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Abbvie ABBV:US $ 16283M 875M
Amgen AMGN:US $ 916M 5784M
AstraZeneca AZN:LN 36340M 2928M
Bristol Myers Squibb BMY:US $ 31580M 4366M
Cytori Therapeutics CYTX:US $ 14.64M 3.81M
Eisai 4523:JP Y 748822M 14034M
Eli Lilly And LLY:US $ 9330.8M 351.6M
Genocea Biosciences GNCA:US $ 12.38M 14.69M
Gilead Sciences GILD:US $ 19927M 1142M
GlaxoSmithKline GSK:LN 16181M 1126M
Infinity Pharmaceuticals INFI:US $ 9.98M 11.59M
Johnson & Johnson JNJ:US $ 74709M 686M
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Novartis NOVN:VX SF 61540M 6115M
Pfizer PFE:US $ 82424M 5224M
Seattle Genetics SGEN:US $ 2998.47M 66.67M
Tg Therapeutics TGTX:US $ 170.39M 66.77M
Vascular Biogenics VBLT:US 42.8M 9.38M
YTE INCY:US $ 3863.07M 93.07M